Lars Gullestad

Publications published between 1979 and 2009 or in press by Lars Gullestad

197 publications found

Publications in press

1. Arora S, Aarones M, Aakhus S, Skaardal R, Aass H, Aukrust P, Kongsgaard E, Gullestad L
   Peak oxygen uptake during cardiopulmonary exercise testing determines response to cardiac resynchronization therapy
   J Cardiol (in press)
   PubMed 22542140
2. Gullestad L, Ueland T, Kjekshus J, Nymo SH, Hulthe J, Muntendam P, Adourian A, Böhm M, van Veldhuisen DJ, Komajda M, Cleland JG, Wikstrand J, McMurray JJ, Aukrust P, on behalf of the CORONA Study Group
   Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
   Eur Heart J (in press)
   PubMed 22513778
3. Solberg OG, Ueland T, Wergeland R, Dahl CP, Aakhus S, Aukrust P, Gullestad L
   High-sensitive troponin T and N-terminal-brain-natriuretic-peptide predict outcome in symptomatic aortic stenosis
   Scand Cardiovasc J (in press)
   PubMed 22545649
4. Ueland T, Aukrust P, Aakhus S, Smith C, Endresen K, Birkeland KI, Gullestad L, Johansen OE
   Activin A and cardiovascular disease in type 2 diabetes mellitus
   Diab Vasc Dis Res (in press)
   PubMed 22234949

Publications 2009

1. Arora S, Aukrust P, Andreassen A, Simonsen S, Gude E, Grov I, Geiran O, Fiane A, Gullestad L (2009)
   The prognostic importance of modifiable risk factors after heart transplantation
   Am Heart J, 158 (3), 431-6
   PubMed 19699867
2. Arora S, Aukrust P, Ueland T, Broch K, Simonsen S, Gude E, Fiane AE, Geiran O, Wergeland R, Andreassen AK, Gullestad L (2009)
   Elevated serum uric acid levels following heart transplantation predict all-cause and cardiac mortality
   Eur J Heart Fail, 11 (10), 1005-13
   PubMed 19737803
3. Aukrust P, Ueland T, Gullestad L, Yndestad A (2009)
   Testosterone: a novel therapeutic approach in chronic heart failure?
   J Am Coll Cardiol, 54 (10), 928-9
   PubMed 19712803
4. Dahl CP, Husberg C, Gullestad L, Waehre A, Damås JK, Vinge LE, Finsen AV, Ueland T, Florholmen G, Aakhus S, Halvorsen B, Aukrust P, Oie E, Yndestad A, Christensen G (2009)
   Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling
   Circ Heart Fail, 2 (6), 624-32
   PubMed 19919988
5. Gjesdal O, Gude E, Arora S, Leivestad T, Andreassen AK, Gullestad L, Aaberge L, Brunvand H, Edvardsen T, Geiran OR, Simonsen S (2009)
   Intra-aortic balloon counterpulsation as a bridge to heart transplantation does not impair long-term survival
   Eur J Heart Fail, 11 (7), 709-14
   PubMed 19515719
6. Heymans S, Hirsch E, Anker SD, Aukrust P, Balligand JL, Cohen-Tervaert JW, Drexler H, Filippatos G, Felix SB, Gullestad L, Hilfiker-Kleiner D, Janssens S, Latini R, Neubauer G, Paulus WJ, Pieske B, Ponikowski P, Schroen B, Schultheiss HP, Tschöpe C, Van Bilsen M, Zannad F, McMurray J, Shah AM (2009)
   Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology
   Eur J Heart Fail, 11 (2), 119-29
   PubMed 19168509
7. Johansen OE, Birkeland KI, Jørgensen AP, Orvik E, Sørgård B, Torjussen BR, Ueland T, Aukrust P, Gullestad L (2009)
   Diabetic foot ulcer burden may be modified by high-dose atorvastatin: A 6-month randomized controlled pilot trial
   J Diabetes, 1 (3), 182-7
   PubMed 20923537
8. Kjekshus JK, Torp-Pedersen C, Gullestad L, Køber L, Edvardsen T, Olsen IC, Sjaastad I, Qvigstad E, Skomedal T, Osnes JB, Levy FO (2009)
   Effect of piboserod, a 5-HT4 serotonin receptor antagonist, on left ventricular function in patients with symptomatic heart failure
   Eur J Heart Fail, 11 (8), 771-8
   PubMed 19567409
9. McMurray JJ, Kjekshus J, Gullestad L, Dunselman P, Hjalmarson A, Wedel H, Lindberg M, Waagstein F, Grande P, Hradec J, Kamenský G, Korewicki J, Kuusi T, Mach F, Ranjith N, Wikstrand J, CORONA Study Group (2009)
   Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis
   Circulation, 120 (22), 2188-96
   PubMed 19917888
10. Sandberg WJ, Halvorsen B, Yndestad A, Smith C, Otterdal K, Brosstad FR, Frøland SS, Olofsson PS, Damås JK, Gullestad L, Hansson GK, Oie E, Aukrust P (2009)
    Inflammatory interaction between LIGHT and proteinase-activated receptor-2 in endothelial cells: potential role in atherogenesis
    Circ Res, 104 (1), 60-8
    PubMed 19023130
11. Sandberg WJ, Otterdal K, Gullestad L, Halvorsen B, Ragnarsson A, Frøland SS, Damås JK, Oie E, Aukrust P, Hansson GK, Yndestad A (2009)
    The tumour necrosis factor superfamily ligand APRIL (TNFSF13) is released upon platelet activation and expressed in atherosclerosis
    Thromb Haemost, 102 (4), 704-10
    PubMed 19806256
12. Semb AG, Ueland T, Aukrust P, Wareham NJ, Luben R, Gullestad L, Kastelein JJ, Khaw KT, Boekholdt SM (2009)
    Osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand and risk for coronary events: a nested case-control approach in the prospective EPIC-Norfolk population study 1993-2003
    Arterioscler Thromb Vasc Biol, 29 (6), 975-80
    PubMed 19325145
13. Ueland T, Otterdal K, Lekva T, Halvorsen B, Gabrielsen A, Sandberg WJ, Paulsson-Berne G, Pedersen TM, Folkersen L, Gullestad L, Oie E, Hansson GK, Aukrust P (2009)
    Dickkopf-1 enhances inflammatory interaction between platelets and endothelial cells and shows increased expression in atherosclerosis
    Arterioscler Thromb Vasc Biol, 29 (8), 1228-34
    PubMed 19498175
14. Yndestad A, Landrø L, Ueland T, Dahl CP, Flo TH, Vinge LE, Espevik T, Frøland SS, Husberg C, Christensen G, Dickstein K, Kjekshus J, Øie E, Gullestad L, Aukrust P (2009)
    Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure
    Eur Heart J, 30 (10), 1229-36
    PubMed 19329498

Publications 2008

1. Arora S, Jenum PA, Aukrust P, Rollag H, Andreassen AK, Simonsen S, Guide E, Fiane AE, Geiran O, Gullestad L (2008)
   Pre-transplant Toxoplasma gondii seropositivlty among heart transplant recipients and mortality - Reply
   J. Am. Coll. Cardiol., 51 (18), 1827-1828
2. Aukrust P, Halvorsen B, Yndestad A, Ueland T, Øie E, Otterdal K, Gullestad L, Damås JK (2008)
   Chemokines and cardiovascular risk
   Arterioscler Thromb Vasc Biol, 28 (11), 1909-19
   PubMed 18669888
3. Aukrust P, Otterdal K, Yndestad A, Sandberg WJ, Smith C, Ueland T, Øie E, Damås JK, Gullestad L, Halvorsen B (2008)
   The complex role of T-cell-based immunity in atherosclerosis
   Curr Atheroscler Rep, 10 (3), 236-43
   PubMed 18489852
4. Breland UM, Halvorsen B, Hol J, Øie E, Paulsson-Berne G, Yndestad A, Smith C, Otterdal K, Hedin U, Waehre T, Sandberg WJ, Frøland SS, Haraldsen G, Gullestad L, Damås JK, Hansson GK, Aukrust P (2008)
   A potential role of the CXC chemokine GROalpha in atherosclerosis and plaque destabilization: downregulatory effects of statins
   Arterioscler Thromb Vasc Biol, 28 (5), 1005-11
   PubMed 18276907
5. Dahl CP, Gullestad L, Fevang B, Holm AM, Landrø L, Vinge LE, Fiane AE, Sandberg WJ, Otterdal K, Frøland SS, Damås JK, Halvorsen B, Aukrust P, Øie E, Yndestad A (2008)
   Increased expression of LIGHT/TNFSF14 and its receptors in experimental and clinical heart failure
   Eur J Heart Fail, 10 (4), 352-9
   PubMed 18353719
6. Halvorsen B, Otterdal K, Dahl TB, Skjelland M, Gullestad L, Øie E, Aukrust P (2008)
   Atherosclerotic plaque stability--what determines the fate of a plaque?
   Prog Cardiovasc Dis, 51 (3), 183-94
   PubMed 19026853
7. Husberg C, Nygård S, Finsen AV, Damås JK, Frigessi A, Oie E, Waehre A, Gullestad L, Aukrust P, Yndestad A, Christensen G (2008)
   Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure
   J Mol Cell Cardiol, 45 (2), 261-9
   PubMed 18585734
8. Johansen OE, Bjurö T, Endresen K, Blaasaas KG, Birkeland K, Aakhus S, Gullestad L (2008)
   Heart rate adjustments and analysis of recovery patterns of ST-segment depression in type 2 diabetes
   Int J Cardiol, 127 (1), 129-32
   PubMed 17532067
9. Otterdal K, Andreassen AK, Yndestad A, Oie E, Sandberg WJ, Dahl CP, Pedersen TM, Ueland T, Gullestad L, Brosstad FR, Aukrust P, Damås JK (2008)
   Raised LIGHT levels in pulmonary arterial hypertension: potential role in thrombus formation
   Am J Respir Crit Care Med, 177 (2), 202-7
   PubMed 17962639
10. Smith C, Halvorsen B, Otterdal K, Waehre T, Yndestad A, Fevang B, Sandberg WJ, Breland UM, Frøland SS, Oie E, Gullestad L, Damås JK, Aukrust P (2008)
    High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins
    Cardiovasc Res, 79 (1), 195-203
    PubMed 18339644

Publications 2007

1. Arora S, Andreassen A, Simonsen S, Gude E, Dahl C, Skaardal R, Hoel I, Geiran O, Gullestad L (2007)
   Prognostic importance of renal function 1 year after heart transplantation for all-cause and cardiac mortality and development of allograft vasculopathy
   Transplantation, 84 (2), 149-54
   PubMed 17667805
2. Arora S, Gullestad L, Wergeland R, Simonsen S, Holm T, Hognestad A, Ueland T, Geiran O, Andreassen A (2007)
   Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation
   Transplantation, 83 (10), 1308-15
   PubMed 17519779
3. Arora S, Jenum PA, Aukrust P, Rollag H, Andreassen AK, Simonsen S, Gude E, Fiane AE, Geiran O, Gullestad L (2007)
   Pre-transplant Toxoplasma gondii seropositivity among heart transplant recipients is associated with an increased risk of all-cause and cardiac mortality
   J Am Coll Cardiol, 50 (20), 1967-72
   PubMed 17996562
4. Aukrust P, Yndestad A, Damås JK, Ueland T, Øie E, Gullestad L (2007)
   Potential mechanisms of benefit with thalidomide in chronic heart failure
   Am J Cardiovasc Drugs, 7 (2), 127-34
   PubMed 17503883
5. Aukrust P, Yndestad A, Sandberg WJ, Gullestad L, Damås JK (2007)
   T cells in coronary artery disease: different effects of different T-cell subsets
   J Am Coll Cardiol, 50 (15), 1459-61
   PubMed 17919565
6. Aukrust P, Yndestad A, Smith C, Ueland T, Gullestad L, Damås JK (2007)
   Chemokines in cardiovascular risk prediction
   Thromb Haemost, 97 (5), 748-54
   PubMed 17479185
7. Dahl TB, Yndestad A, Skjelland M, Øie E, Dahl A, Michelsen A, Damås JK, Tunheim SH, Ueland T, Smith C, Bendz B, Tonstad S, Gullestad L, Frøland SS, Krohg-Sørensen K, Russell D, Aukrust P, Halvorsen B (2007)
   Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization
   Circulation, 115 (8), 972-80
   PubMed 17283255
8. Damås JK, Smith C, Øie E, Fevang B, Halvorsen B, Waehre T, Boullier A, Breland U, Yndestad A, Ovchinnikova O, Robertson AK, Sandberg WJ, Kjekshus J, Taskén K, Frøland SS, Gullestad L, Hansson GK, Quehenberger O, Aukrust P (2007)
   Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization
   Arterioscler Thromb Vasc Biol, 27 (3), 614-20
   PubMed 17170367
9. Gullestad L, Madsen S (2007)
   [Diuretics not the first-choice-drug in chronic heart failure]
   Tidsskr Nor Laegeforen, 127 (5), 621; author reply 621
   PubMed 17332822
10. Gullestad L, Oie E, Ueland T, Yndestad A, Aukrust P (2007)
    The role of statins in heart failure
    Fundam Clin Pharmacol, 21 Suppl 2, 35-40
    PubMed 18001320
11. Havik OE, Sivertsen B, Relbo A, Hellesvik M, Grov I, Geiran O, Andreassen AK, Simonsen S, Gullestad L (2007)
    Depressive symptoms and all-cause mortality after heart transplantation
    Transplantation, 84 (1), 97-103
    PubMed 17627244
12. Johansen OE, Birkeland KI, Orvik E, Flesland Ø, Wergeland R, Ueland T, Smith C, Endresen K, Aukrust P, Gullestad L (2007)
    Inflammation and coronary angiography in asymptomatic type 2 diabetic subjects
    Scand J Clin Lab Invest, 67 (3), 306-16
    PubMed 17454845
13. Johansen OE, Gullestad L, Blaasaas KG, Orvik E, Birkeland KI (2007)
    Effects of structured hospital-based care compared with standard care for Type 2 diabetes-The Asker and Baerum Cardiovascular Diabetes Study, a randomized trial
    Diabet Med, 24 (9), 1019-27
    PubMed 17509068
14. Kjekshus J, Apetrei E, Barrios V, Böhm M, Cleland JG, Cornel JH, Dunselman P, Fonseca C, Goudev A, Grande P, Gullestad L, Hjalmarson A, Hradec J, Jánosi A, Kamenský G, Komajda M, Korewicki J, Kuusi T, Mach F, Mareev V, McMurray JJ, Ranjith N, Schaufelberger M, Vanhaecke J, van Veldhuisen DJ et al. (2007)
    Rosuvastatin in older patients with systolic heart failure
    N Engl J Med, 357 (22), 2248-61
    PubMed 17984166
15. Simonsen S, Andreassen AK, Gullestad L, Leivestad T, Fiane AE, Geiran OR (2007)
    [Survival after heart transplantation in Norway]
    Tidsskr Nor Laegeforen, 127 (7), 865-8
    PubMed 17435806
16. Sivertsen B, Relbo A, Gullestad L, Hellesvik M, Grov I, Andreassen A, Simonsen S, Geiran O, Havik OE (2007)
    [Self-assessed health and psychological symptoms after heart transplantation]
    Tidsskr Nor Laegeforen, 127 (24), 3198-201
    PubMed 18084359
17. Yndestad A, Damås JK, Øie E, Ueland T, Gullestad L, Aukrust P (2007)
    Role of inflammation in the progression of heart failure
    Curr Cardiol Rep, 9 (3), 236-41
    PubMed 17470337

Publications 2006

1. Aukrust P, Yndestad A, Ueland T, Damås JK, Frøland SS, Gullestad L (2006)
   The role of intravenous immunoglobulin in the treatment of chronic heart failure
   Int J Cardiol, 112 (1), 40-5
   PubMed 16893578
2. Aukrust P, Yndestad A, Ueland T, Damås JK, Gullestad L (2006)
   Anti-inflammatory trials in chronic heart failure
   Heart Fail Monit, 5 (1), 2-9
   PubMed 16547529
3. Holm T, Ueland T, Halvorsen B, Hognestad A, Holm AG, Wergeland R, Gullestad L, Aukrust P, Kjekshus J (2006)
   A protective anti-inflammatory phenotype in high-risk individuals who do not develop coronary artery disease
   J Am Coll Cardiol, 47 (5), 1085-6
   PubMed 16516099
4. Johansen OE, Birkeland KI, Brustad E, Aaser E, Lindahl AK, Midha R, Ueland T, Aukrust P, Gullestad L (2006)
   Undiagnosed dysglycaemia and inflammation in cardiovascular disease
   Eur J Clin Invest, 36 (8), 544-51
   PubMed 16893376
5. Sandberg WJ, Yndestad A, Øie E, Smith C, Ueland T, Ovchinnikova O, Robertson AK, Müller F, Semb AG, Scholz H, Andreassen AK, Gullestad L, Damås JK, Frøland SS, Hansson GK, Halvorsen B, Aukrust P (2006)
   Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization
   Arterioscler Thromb Vasc Biol, 26 (4), 857-63
   PubMed 16424351
6. Smith C, Damås JK, Otterdal K, Øie E, Sandberg WJ, Yndestad A, Waehre T, Scholz H, Endresen K, Olofsson PS, Halvorsen B, Gullestad L, Frøland SS, Hansson GK, Aukrust P (2006)
   Increased levels of neutrophil-activating peptide-2 in acute coronary syndromes: possible role of platelet-mediated vascular inflammation
   J Am Coll Cardiol, 48 (8), 1591-9
   PubMed 17045893
7. Ueland T, Aukrust P, Damas JK, Gullestad L, Yndestad A (2006)
   The tumor necrosis factor superfamily in heart failure
   Future Cardiol, 2 (1), 101-11
   PubMed 19804137
8. Ueland T, Espevik T, Kjekshus J, Gullestad L, Omland T, Squire IB, Frøland SS, Mollnes TE, Dickstein K, Aukrust P (2006)
   Mannose binding lectin and soluble Toll-like receptor 2 in heart failure following acute myocardial infarction
   J Card Fail, 12 (8), 659-63
   PubMed 17045187
9. Ueland T, Gullestad L, Simonsen S, Endresen K, Scott H, Frøland SS, Geiran O, Fiane AE, Aukrust P (2006)
   Decreased endomyocardial RANKL expression in transplant coronary artery disease
   Transplantation, 81 (10), 1467-70
   PubMed 16732187
10. Ueland T, Vissers MN, Wiegman A, Rodenburg J, Hutten B, Gullestad L, Ose L, Rifai N, Ridker PM, Kastelein JJ, Aukrust P, Semb AG (2006)
    Increased inflammatory markers in children with familial hypercholesterolaemia
    Eur J Clin Invest, 36 (3), 147-52
    PubMed 16506958
11. van Veldhuisen DJ, Aass H, El Allaf D, Dunselman PH, Gullestad L, Halinen M, Kjekshus J, Ohlsson L, Wedel H, Wikstrand J, MERIT-HF Study Group (2006)
    Presence and development of atrial fibrillation in chronic heart failure. Experiences from the MERIT-HF Study
    Eur J Heart Fail, 8 (5), 539-46
    PubMed 16567126
12. Waehre T, Damås JK, Pedersen TM, Gullestad L, Yndestad A, Andreassen AK, Frøland SS, Semb AG, Hansteen V, Gjertsen E, Ueland T, Brosstad F, Solum NO, Aukrust P (2006)
    Clopidogrel increases expression of chemokines in peripheral blood mononuclear cells in patients with coronary artery disease: results of a double-blind placebo-controlled study
    J Thromb Haemost, 4 (10), 2140-7
    PubMed 16856976
13. Yndestad A, Damås JK, Oie E, Ueland T, Gullestad L, Aukrust P (2006)
    Systemic inflammation in heart failure--the whys and wherefores
    Heart Fail Rev, 11 (1), 83-92
    PubMed 16819581

Publications 2005

1. Aukrust P, Gullestad L, Ueland T, Damås JK, Yndestad A (2005)
   Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapeutic implications
   Ann Med, 37 (2), 74-85
   PubMed 16026115
2. Aukrust P, Yndestad A, Smith C, Sandberg WJ, Ueland T, Waehre T, Halvorsen B, Gullestad L, Damås JK (2005)
   Potential role for immunomodulatory therapy in atherosclerotic plaque stabilisation
   Expert Opin Pharmacother, 6 (13), 2169-80
   PubMed 16218879
3. Aukrust P, Yndestad A, Waehre T, Gullestad L, Halvorsen B, Damås JK (2005)
   Inflammation in coronary artery disease: potential role for immunomodulatory therapy
   Expert Rev Cardiovasc Ther, 3 (6), 1111-24
   PubMed 16293001
4. Fiane AE, Ueland T, Simonsen S, Scott H, Endresen K, Gullestad L, Geiran OR, Haraldsen G, Heggelund L, Andreassen AK, Wergeland R, Frøland S, Aukrust P, Mollnes TE (2005)
   Low mannose-binding lectin and increased complement activation correlate to allograft vasculopathy, ischaemia, and rejection after human heart transplantation
   Eur Heart J, 26 (16), 1660-5
   PubMed 15821010
5. Gullestad L, Aukrust P (2005)
   Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approaches
   Am J Cardiol, 95 (11A), 17C-23C; discussion 38C-40C
   PubMed 15925560
6. Gullestad L, Kjekshus J, Damås JK, Ueland T, Yndestad A, Aukrust P (2005)
   Agents targeting inflammation in heart failure
   Expert Opin Investig Drugs, 14 (5), 557-66
   PubMed 15926863
7. Gullestad L, Ueland T, Fjeld JG, Holt E, Gundersen T, Breivik K, Følling M, Hodt A, Skårdal R, Kjekshus J, Andreassen A, Kjekshus E, Wergeland R, Yndestad A, Frøland SS, Semb AG, Aukrust P (2005)
   Effect of thalidomide on cardiac remodeling in chronic heart failure: results of a double-blind, placebo-controlled study
   Circulation, 112 (22), 3408-14
   PubMed 16301340
8. Gullestad L, Wikstrand J, Deedwania P, Hjalmarson A, Egstrup K, Elkayam U, Gottlieb S, Rashkow A, Wedel H, Bermann G, Kjekshus J, MERIT-HF Study Group (2005)
   What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF)
   J Am Coll Cardiol, 45 (2), 252-9
   PubMed 15653024
9. Scholz H, Sandberg W, Damås JK, Smith C, Andreassen AK, Gullestad L, Frøland SS, Yndestad A, Aukrust P, Halvorsen B (2005)
   Enhanced plasma levels of LIGHT in unstable angina: possible pathogenic role in foam cell formation and thrombosis
   Circulation, 112 (14), 2121-9
   PubMed 16186421
10. Ueland T, Aukrust P, Yndestad A, Otterdal K, Frøland SS, Dickstein K, Kjekshus J, Gullestad L, Damås JK (2005)
    Soluble CD40 ligand in acute and chronic heart failure
    Eur Heart J, 26 (11), 1101-7
    PubMed 15716285
11. Ueland T, Kjekshus J, Frøland SS, Omland T, Squire IB, Gullestad L, Dickstein K, Aukrust P (2005)
    Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients
    J Am Coll Cardiol, 46 (11), 2018-21
    PubMed 16325035
12. Ueland T, Yndestad A, Øie E, Florholmen G, Halvorsen B, Frøland SS, Simonsen S, Christensen G, Gullestad L, Aukrust P (2005)
    Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure
    Circulation, 111 (19), 2461-8
    PubMed 15883214

Publications 2004

1. Aukrust P, Yndestad A, Damås JK, Gullestad L (2004)
   Therapeutic potential of anticytokine therapy in congestive heart failure
   Am J Cardiovasc Drugs, 4 (3), 169-77
   PubMed 15134469
2. Aukrust P, Yndestad A, Damås JK, Gullestad L (2004)
   Inflammation and chronic heart failure-potential therapeutic role of intravenous immunoglobulin
   Autoimmun Rev, 3 (3), 221-7
   PubMed 15110235
3. Bjurö T, Gullestad L, Endresen K, Nordlander M, Malm A, Höglund L, Wahlqvist I, Pernow J (2004)
   Evaluation of ST-segment changes during and after maximal exercise tests in one-, two- and three-vessel coronary artery disease
   Scand Cardiovasc J, 38 (5), 270-7
   PubMed 15513309
4. Gullestad L, Madsen S (2004)
   [Modern diagnosis and treatment of heart failure]
   Tidsskr Nor Laegeforen, 124 (8), 1107-10
   PubMed 15114390
5. Gullestad L, Myers J, Edvardsen T, Kjekshus J, Geiran O, Simonsen S (2004)
   Predictors of exercise capacity and the impact of angiographic coronary artery disease in heart transplant recipients
   Am Heart J, 147 (1), 49-54
   PubMed 14691418
6. Hognestad A, Aukrust P, Wergeland R, Stokke O, Gullestad L, Semb AG, Holm T, Andreassen AK, Kjekshus JK (2004)
   Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation
   Clin Cardiol, 27 (4), 199-203
   PubMed 15119693
7. Hole T, Frøland G, Gullestad L, Offstad J, Skjaerpe T (2004)
   Metoprolol CR/XL improves systolic and diastolic left ventricular function in patients with chronic heart failure
   Echocardiography, 21 (3), 215-23
   PubMed 15053783
8. Larsson L, Mobini R, Aukrust P, Gullestad L, Wallukat G, Waagstein F, Fu M (2004)
   Beneficial effect on cardiac function by intravenous immunoglobulin treatment in patients with dilated cardiomyopathy is not due to neutralization of anti-receptor autoantibody
   Autoimmunity, 37 (6-7), 489-93
   PubMed 15621576
9. Smith C, Yndestad A, Halvorsen B, Ueland T, Waehre T, Otterdal K, Scholz H, Endresen K, Gullestad L, Frøland SS, Damås JK, Aukrust P (2004)
   Potential anti-inflammatory role of activin A in acute coronary syndromes
   J Am Coll Cardiol, 44 (2), 369-75
   PubMed 15261933
10. Tveit A, Grundtvig M, Gundersen T, Vanberg P, Semb AG, Holt E, Gullestad L (2004)
    Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion
    Am J Cardiol, 93 (6), 780-2
    PubMed 15019894
11. Ueland T, Jemtland R, Godang K, Kjekshus J, Hognestad A, Omland T, Squire IB, Gullestad L, Bollerslev J, Dickstein K, Aukrust P (2004)
    Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction
    J Am Coll Cardiol, 44 (10), 1970-6
    PubMed 15542278
12. Waehre T, Yndestad A, Smith C, Haug T, Tunheim SH, Gullestad L, Frøland SS, Semb AG, Aukrust P, Damås JK (2004)
    Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors
    Circulation, 109 (16), 1966-72
    PubMed 15051633
13. Yndestad A, Ueland T, Øie E, Florholmen G, Halvorsen B, Attramadal H, Simonsen S, Frøland SS, Gullestad L, Christensen G, Damås JK, Aukrust P (2004)
    Elevated levels of activin A in heart failure: potential role in myocardial remodeling
    Circulation, 109 (11), 1379-85
    PubMed 14993131

Publications 2003

1. Aukrust P, Damås JK, Gullestad L (2003)
   Immunomodulating therapy: new treatment modality in congestive heart failure
   Congest Heart Fail, 9 (2), 64-9
   PubMed 12671336
2. Damås JK, Waehre T, Yndestad A, Otterdal K, Hognestad A, Solum NO, Gullestad L, Frøland SS, Aukrust P (2003)
   Interleukin-7-mediated inflammation in unstable angina: possible role of chemokines and platelets
   Circulation, 107 (21), 2670-6
   PubMed 12742982
3. Gullestad L, Bjurø T, Aaberge L, Apelland T, Skårdal R, Kjekshus E, Nordlander M, Ablad B, Pernow J (2003)
   The effect of a neuropeptide Y Y1 receptor antagonist in patients with angina pectoris
   Eur Heart J, 24 (12), 1120-7
   PubMed 12804926
4. Gullestad L, Kjekshus J (2003)
   [Use of beta-blockaders in heart failure]
   Tidsskr Nor Laegeforen, 123 (5), 651-2
   PubMed 12683197
5. Holm T, Damås JK, Holven K, Nordøy I, Brosstad FR, Ueland T, Währe T, Kjekshus J, Frøland SS, Eiken HG, Solum NO, Gullestad L, Nenseter M, Aukrust P (2003)
   CXC-chemokines in coronary artery disease: possible pathogenic role of interactions between oxidized low-density lipoprotein, platelets and peripheral blood mononuclear cells
   J Thromb Haemost, 1 (2), 257-62
   PubMed 12871498
6. Myers J, Geiran O, Simonsen S, Ghuyoumi A, Gullestad L (2003)
   Clinical and exercise test determinants of survival after cardiac transplantation
   Chest, 124 (5), 2000-5
   PubMed 14605079
7. Myers J, Gullestad L, Bellin D, Ross H, Vagelos R, Fowler M (2003)
   Physical activity patterns and exercise performance in cardiac transplant recipients
   J Cardiopulm Rehabil, 23 (2), 100-6
   PubMed 12668931
8. Ronnevig M, Bjorsvik E, Gullestad L, Forfang K (2003)
   A descriptive study of early nonspecific chest pain after PTCA: important area for the acute health care personnel
   Heart Lung, 32 (4), 241-9
   PubMed 12891164
9. Semb AG, van Wissen S, Ueland T, Smilde T, Waehre T, Tripp MD, Frøland SS, Kastelein JJ, Gullestad L, Pedersen TR, Aukrust P, Stalenhoef AF (2003)
   Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy
   J Am Coll Cardiol, 41 (2), 275-9
   PubMed 12535822
10. Ueland T, Sikkeland LI, Yndestad A, Eiken HG, Holm T, Guevara C, Haug T, Endresen K, Frøland SS, Gullestad L, Andreassen AK, Geiran O, Simonsen S, Aukrust P (2003)
    Myocardial gene expression of inflammatory cytokines after heart transplantation in relation to the development of transplant coronary artery disease
    Am J Cardiol, 92 (6), 715-7
    PubMed 12972116
11. Waehre T, Damås JK, Gullestad L, Holm AM, Pedersen TR, Arnesen KE, Torsvik H, Frøland SS, Semb AG, Aukrust P (2003)
    Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease
    J Am Coll Cardiol, 41 (9), 1460-7
    PubMed 12742282
12. Yndestad A, Holm AM, Müller F, Simonsen S, Frøland SS, Gullestad L, Aukrust P (2003)
    Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure
    Cardiovasc Res, 60 (1), 141-6
    PubMed 14522416

Publications 2002

1. Damås JK, Waehre T, Yndestad A, Ueland T, Müller F, Eiken HG, Holm AM, Halvorsen B, Frøland SS, Gullestad L, Aukrust P (2002)
   Stromal cell-derived factor-1alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects
   Circulation, 106 (1), 36-42
   PubMed 12093767
2. Gottlieb SS, Fisher ML, Kjekshus J, Deedwania P, Gullestad L, Vitovec J, Wikstrand J, MERIT-HF Investigators (2002)
   Tolerability of beta-blocker initiation and titration in the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)
   Circulation, 105 (10), 1182-8
   PubMed 11889011
3. Gullestad L, Semb AG, Holt E, Skårdal R, Ueland T, Yndestad A, Frøland SS, Aukrust P (2002)
   Effect of thalidomide in patients with chronic heart failure
   Am Heart J, 144 (5), 847-50
   PubMed 12422154
4. Holm T, Aukrust P, Aagaard E, Ueland T, Haugstad TS, Kjekshus J, Simonsen S, Frøland SS, Gullestad L, Andreassen AK (2002)
   Hypertension in relation to nitric oxide, asymmetric dimethylarginine, and inflammation: different patterns in heart transplant recipients and individuals with essential hypertension
   Transplantation, 74 (10), 1395-400
   PubMed 12451238
5. Lund TM, Torsvik H, Falch D, Christophersen B, Skårdal R, Gullestad L (2002)
   Effect of morning versus evening intake of simvastatin on the serum cholesterol level in patients with coronary artery disease
   Am J Cardiol, 90 (7), 784-6
   PubMed 12356401
6. Waehre T, Halvorsen B, Damås JK, Yndestad A, Brosstad F, Gullestad L, Kjekshus J, Frøland SS, Aukrust P (2002)
   Inflammatory imbalance between IL-10 and TNFalpha in unstable angina potential plaque stabilizing effects of IL-10
   Eur J Clin Invest, 32 (11), 803-10
   PubMed 12423320
7. Yndestad A, Damås JK, Geir Eiken H, Holm T, Haug T, Simonsen S, Frøland SS, Gullestad L, Aukrust P (2002)
   Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failure
   Cardiovasc Res, 54 (1), 175-82
   PubMed 12062373

Publications 2001

1. Aukrust P, Berge RK, Ueland T, Aaser E, Damås JK, Wikeby L, Brunsvig A, Müller F, Forfang K, Frøland SS, Gullestad L (2001)
   Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes
   J Am Coll Cardiol, 37 (2), 485-91
   PubMed 11216967
2. Aukrust P, Damås JK, Gullestad L, Frøland SS (2001)
   Chemokines in myocardial failure -- pathogenic importance and potential therapeutic targets
   Clin Exp Immunol, 124 (3), 343-5
   PubMed 11472392
3. Aukrust P, Gullestad L, Lappegård KT, Ueland T, Aass H, Wikeby L, Simonsen S, Frøland SS, Mollnes TE (2001)
   Complement activation in patients with congestive heart failure: effect of high-dose intravenous immunoglobulin treatment
   Circulation, 104 (13), 1494-500
   PubMed 11571242
4. Aukrust P, Gullestad L, Aass H, Fjeld JG, Wikeby L, Andreassen AK, Ihlen H, Simonsen S, Kjekshus J, Nitter-Hauge S, Ueland T, Froland SS (2001)
   Increase in anti-inflammatory cytokine levels in chronic heart failure: A measure of treatment success or failure? Response
   Circulation, 104 (18), E97-E98
5. Aukrust P, Waehre T, Damås JK, Gullestad L, Solum NO (2001)
   Inflammatory role of platelets in acute coronary syndromes
   Heart, 86 (6), 605-6
   PubMed 11711447
6. Dahle MG, Gullestad L, Simonsen S (2001)
   Plasma N-terminal proatrial natriuretic factor can predict normal pulmonary capillary wedge pressure in cardiac transplant recipients
   Scand Cardiovasc J, 35 (6), 367-71
   PubMed 11837515
7. Damås JK, Aukrust P, Ueland T, Odegaard A, Eiken HG, Gullestad L, Sejersted OM, Christensen G (2001)
   Monocyte chemoattractant protein-1 enhances and interleukin-10 suppresses the production of inflammatory cytokines in adult rat cardiomyocytes
   Basic Res Cardiol, 96 (4), 345-52
   PubMed 11518190
8. Damås JK, Gullestad L, Aukrust P (2001)
   Cytokines as new treatment targets in chronic heart failure
   Curr Control Trials Cardiovasc Med, 2 (6), 271-277
   PubMed 11806813
9. Damås JK, Gullestad L, Aass H, Simonsen S, Fjeld JG, Wikeby L, Ueland T, Eiken HG, Frøland SS, Aukrust P (2001)
   Enhanced gene expression of chemokines and their corresponding receptors in mononuclear blood cells in chronic heart failure--modulatory effect of intravenous immunoglobulin
   J Am Coll Cardiol, 38 (1), 187-93
   PubMed 11451272
10. Eiken HG, Øie E, Damås JK, Yndestad A, Bjerkeli V, Aass H, Simonsen S, Geiran OR, Tønnessen T, Christensen G, Frøland SS, Gullestad L, Attramadal H, Aukrust P (2001)
    Myocardial gene expression of leukaemia inhibitory factor, interleukin-6 and glycoprotein 130 in end-stage human heart failure
    Eur J Clin Invest, 31 (5), 389-97
    PubMed 11380590
11. Gullestad L, Aukrust P (2001)
    The cytokine network in heart failure: pathogenetic importance and potential therapeutic targets
    Heart Fail Monit, 2 (1), 8-13
    PubMed 12634893
12. Gullestad L, Manhenke C, Aarsland T, Skårdal R, Fagertun H, Wikstrand J, Kjekshus J (2001)
    Effect of metoprolol CR/XL on exercise tolerance in chronic heart failure - a substudy to the MERIT-HF trial
    Eur J Heart Fail, 3 (4), 463-8
    PubMed 11511433
13. Gullestad L, Ueland T, Brunsvig A, Kjekshus J, Simonsen S, Frøland SS, Aukrust P (2001)
    Effect of metoprolol on cytokine levels in chronic heart failure--a substudy in the Metoprolol Controlled-Release Randomised Intervention Trial in Heart Failure (MERIT-HF)
    Am Heart J, 141 (3), 418-21
    PubMed 11231439
14. Gullestad L, Aass H, Andreassen AK, Ihlen H, Simonsen S, Kjekshus J, Wikeby L, Nitter-Hauge S, Fjeld JG, Lien E, Ueland T, Frøland SS, Aukrust P (2001)
    [Immunomodulating treatment in advanced heart failure--effect of intravenous immunoglobulin]
    Tidsskr Nor Laegeforen, 121 (16), 1902-7
    PubMed 11488180
15. Gullestad L, Aass H, Fjeld JG, Wikeby L, Andreassen AK, Ihlen H, Simonsen S, Kjekshus J, Nitter-Hauge S, Ueland T, Lien E, Frøland SS, Aukrust P (2001)
    Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure
    Circulation, 103 (2), 220-5
    PubMed 11208680
16. Holm T, Andreassen AK, Aukrust P, Andersen K, Geiran OR, Kjekshus J, Simonsen S, Gullestad L (2001)
    Omega-3 fatty acids improve blood pressure control and preserve renal function in hypertensive heart transplant recipients
    Eur Heart J, 22 (5), 428-36
    PubMed 11207085
17. Holm T, Andreassen AK, Ueland T, Kjekshus J, Frøland SS, Kjekshus E, Simonsen S, Aukrust P, Gullestad L (2001)
    Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients
    Am J Cardiol, 87 (6), 815-8, A9
    PubMed 11249916
18. Holm T, Berge RK, Andreassen AK, Ueland T, Kjekshus J, Simonsen S, Frøland S, Gullestad L, Aukrust P (2001)
    Omega-3 fatty acids enhance tumor necrosis factor-alpha levels in heart transplant recipients
    Transplantation, 72 (4), 706-11
    PubMed 11544435
19. Holven KB, Holm T, Aukrust P, Christensen B, Kjekshus J, Andreassen AK, Gullestad L, Hagve TA, Svilaas A, Ose L, Nenseter MS (2001)
    Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects
    Am J Med, 110 (7), 536-42
    PubMed 11343667

Publications 2000

1. Damås JK, Eiken HG, Oie E, Bjerkeli V, Yndestad A, Ueland T, Tonnessen T, Geiran OR, Aass H, Simonsen S, Christensen G, Froland SS, Attramadal H, Gullestad L, Aukrust P (2000)
   Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure
   Cardiovasc Res, 47 (4), 778-87
   PubMed 10974226
2. Damås JK, Gullestad L, Ueland T, Solum NO, Simonsen S, Frøland SS, Aukrust P (2000)
   CXC-chemokines, a new group of cytokines in congestive heart failure--possible role of platelets and monocytes
   Cardiovasc Res, 45 (2), 428-36
   PubMed 10728363
3. Gullestad L, Jorgensen B, Bjuro T, Pernow J, Lundberg JM, Dota CD, Hall C, Simonsen S, Ablad B (2000)
   Postexercise ischemia is associated with increased neuropeptide Y in patients with coronary artery disease
   Circulation, 102 (9), 987-93
   PubMed 10961962
4. Hjalmarson A, Goldstein S, Fagerberg B, Wedel H, Waagstein F, Kjekshus J, Wikstrand J, El Allaf D, Vítovec J, Aldershvile J, Halinen M, Dietz R, Neuhaus KL, Jánosi A, Thorgeirsson G, Dunselman PH, Gullestad L, Kuch J, Herlitz J, Rickenbacher P, Ball S, Gottlieb S, Deedwania P (2000)
   Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group
   JAMA, 283 (10), 1295-302
   PubMed 10714728
5. Holm T, Aukrust P, Andreassen AK, Ueland T, Brosstad F, Frøland SS, Simonsen S, Gullestad L (2000)
   Peripheral endothelial dysfunction in heart transplant recipients: possible role of proinflammatory cytokines
   Clin Transplant, 14 (3), 218-25
   PubMed 10831080
6. Myers J, Gullestad L, Vagelos R, Do D, Bellin D, Ross H, Fowler MB (2000)
   Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited
   Am Heart J, 139 (1 Pt 1), 78-84
   PubMed 10618566

Publications 1999

1. Aukrust P, Gullestad L, Frøland SS (1999)
   Is apoptosis an important pathogenic factor in cardiovascular disease?
   Eur J Clin Invest, 29 (5), 369-71
   PubMed 10354192
2. Aukrust P, Müller F, Ueland T, Berget T, Aaser E, Brunsvig A, Solum NO, Forfang K, Frøland SS, Gullestad L (1999)
   Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes
   Circulation, 100 (6), 614-20
   PubMed 10441098
3. Aukrust P, Ueland T, Lien E, Bendtzen K, Müller F, Andreassen AK, Nordøy I, Aass H, Espevik T, Simonsen S, Frøland SS, Gullestad L (1999)
   Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
   Am J Cardiol, 83 (3), 376-82
   PubMed 10072227
4. Gullestad L, Aukrust P, Ueland T, Espevik T, Yee G, Vagelos R, Frøland SS, Fowler M (1999)
   Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure
   J Am Coll Cardiol, 34 (7), 2061-7
   PubMed 10588224
5. Gullestad L, Bjørnerheim R, Offstad J, Endresen K, Forfang K, Kjekshus J, Hansteen V (1999)
   [Current use of beta-blockers in coronary artery disease]
   Tidsskr Nor Laegeforen, 119 (1), 24-8
   PubMed 10025200
6. Gullestad L, Nordal KP, Berg KJ, Cheng H, Schwartz MS, Simonsen S (1999)
   Interaction between lovastatin and cyclosporine A after heart and kidney transplantation
   Transplant Proc, 31 (5), 2163-5
   PubMed 10456002
7. Gullestad L, Simonsen S, Ueland T, Holm T, Aass H, Andreassen AK, Madsen S, Geiran O, Frøland SS, Aukrust P (1999)
   Possible role of proinflammatory cytokines in heart allograft coronary artery disease
   Am J Cardiol, 84 (9), 999-1003
   PubMed 10569653
8. Kjekshus J, Gullestad L (1999)
   Heart rate as a therapeutic target in heart failure
   Eur. Heart J. Suppl., 1 (H), H64-H69
9. Simonsen S, Andreassen AK, Gullestad L, Lindberg H, Seem E, Geiran OR (1999)
   [Heart transplantation in Norway]
   Tidsskr Nor Laegeforen, 119 (23), 3447-50
   PubMed 10553344

Publications 1998

1. Andreassen AK, Gullestad L, Endresen K (1998)
   [Thrombolytic treatment in acute myocardial infarction. Choice of preparations in Norwegian hospitals]
   Tidsskr Nor Laegeforen, 118 (17), 2630-1
   PubMed 9673511
2. Andreassen AK, Gullestad L, Holm T, Simonsen S, Kvernebo K (1998)
   Endothelium-dependent vasodilation of the skin microcirculation in heart transplant recipients
   Clin Transplant, 12 (4), 324-32
   PubMed 9686327
3. Andreassen AK, Kirkebøen KA, Gullestad L, Simonsen S, Kvernebo K (1998)
   Effect of heart transplantation on impaired peripheral microvascular perfusion and reactivity in congestive heart failure
   Int J Cardiol, 65 (1), 33-40
   PubMed 9699928
4. Andreassen AK, Kvernebo K, Jørgensen B, Simonsen S, Kjekshus J, Gullestad L (1998)
   Exercise capacity in heart transplant recipients: relation to impaired endothelium-dependent vasodilation of the peripheral microcirculation
   Am Heart J, 136 (2), 320-8
   PubMed 9704697
5. Andreassen AK, Nordøy I, Simonsen S, Ueland T, Müller F, Frøland SS, Gullestad L, Aukrust P (1998)
   Levels of circulating adhesion molecules in congestive heart failure and after heart transplantation
   Am J Cardiol, 81 (5), 604-8
   PubMed 9514458
6. Aukrust P, Ueland T, Müller F, Andreassen AK, Nordøy I, Aas H, Kjekshus J, Simonsen S, Frøland SS, Gullestad L (1998)
   Elevated circulating levels of C-C chemokines in patients with congestive heart failure
   Circulation, 97 (12), 1136-43
   PubMed 9537339
7. Gullestad L, Birkeland K, Bjønerheim R, Djøseland O, Trygstad O, Simonsen S (1998)
   Exercise capacity and hormonal response in adults with childhood onset growth hormone deficiency during long-term somatropin treatment
   Growth Horm IGF Res, 8 (5), 377-84
   PubMed 10984298
8. Gullestad L, Haywood G, Aass H, Ross H, Yee G, Ueland T, Geiran O, Kjekshus J, Simonsen S, Bishopric N, Fowler M (1998)
   Angiotensin II receptor subtype AT1 and AT2 expression after heart transplantation
   Cardiovasc Res, 38 (2), 340-7
   PubMed 9709394
9. Gullestad L, Myers J, Ross H, Rickenbacher P, Slauson S, Bellin D, Do D, Vagelos R, Fowler M (1998)
   Serial exercise testing and prognosis in selected patients considered for cardiac transplantation
   Am Heart J, 135 (2 Pt 1), 221-9
   PubMed 9489968
10. Gullestad L, Aass H, Ross H, Ueland T, Geiran O, Kjekshus J, Simonsen S, Fowler M, Kobilka B (1998)
    Neuropeptide Y receptor 1 (NPY-Y1) expression in human heart failure and heart transplantation
    J Auton Nerv Syst, 70 (1-2), 84-91
    PubMed 9686908
11. Myers J, Gullestad L (1998)
    The role of exercise testing and gas-exchange measurement in the prognostic assessment of patients with heart failure
    Curr Opin Cardiol, 13 (3), 145-55
    PubMed 9649936
12. Myers J, Gullestad L, Vagelos R, Do D, Bellin D, Ross H, Fowler MB (1998)
    Clinical, hemodynamic, and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure
    Ann Intern Med, 129 (4), 286-93
    PubMed 9729181
13. Risum O, Arafa O, Svennevig JL, Levorstad K, Abdelnoor M, Gullestad L, Bjørnerheim R, Simonsen S, Nitter-Hauge S (1998)
    [Mortality and morbidity after coronary bypass surgery in high-risk patients]
    Tidsskr Nor Laegeforen, 118 (29), 4504-8
    PubMed 9889633

Publications 1997

1. Gullestad L, Myers J, Bjornerheim R, Berg KJ, Djoseland O, Hall C, Lund K, Kjekshus J, Simonsen S (1997)
   Gas exchange and neurohumoral response to exercise: influence of the exercise protocol
   Med Sci Sports Exerc, 29 (4), 496-502
   PubMed 9107632
2. Gullestad L, Nordal KP, Forfang K, Ihlen H, Høstmark A, Berg KJ, Cheng H, Schwartz MS, Geiran O, Simonsen S (1997)
   Post-transplant hyperlipidaemia: low-dose lovastatin lowers atherogenic lipids without plasma accumulation of lovastatin
   J Intern Med, 242 (6), 483-90
   PubMed 9437409
3. Gullestad L, Ross H, Myers J, Hoang K, Hunt S, Stinson EB, Valantine HA (1997)
   Importance of decreased heart rate in predicting transplant coronary artery disease
   Clin Transplant, 11 (6), 628-32
   PubMed 9408698
4. Haywood GA, Gullestad L, Katsuya T, Hutchinson HG, Pratt RE, Horiuchi M, Fowler MB (1997)
   AT1 and AT2 angiotensin receptor gene expression in human heart failure
   Circulation, 95 (5), 1201-6
   PubMed 9054850
5. Kløw NE, Smith HJ, Gullestad L, Seem E, Endresen K (1997)
   Outcome of bypass surgery in patients with chronic ischemic left ventricular dysfunction. Predictive value of MR imaging
   Acta Radiol, 38 (1), 76-82
   PubMed 9059406
6. Ross HJ, Gullestad L, Pak J, Slauson S, Valantine HA, Hunt SA (1997)
   Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study
   J Heart Lung Transplant, 16 (2), 179-89
   PubMed 9059929
7. Aaser E, Gullestad L, Tølløfsrud S, Lundberg J, Hall C, Djøseland O, Kjekshus J, Forfang K (1997)
   Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure
   Scand J Clin Lab Invest, 57 (4), 361-7
   PubMed 9249883

Publications 1996

1. Gullestad L, Hallen J, Medbø JI, Grønnerød O, Holme I, Sejersted OM (1996)
   The effect of acute vs chronic treatment with beta-adrenoceptor blockade on exercise performance, haemodynamic and metabolic parameters in healthy men and women
   Br J Clin Pharmacol, 41 (1), 57-67
   PubMed 8824694
2. Gullestad L, Haywood G, Ross H, Bjornerheim R, Geiran O, Kjekshus J, Simonsen S, Fowler M (1996)
   Exercise capacity of heart transplant recipients: the importance of chronotropic incompetence
   J Heart Lung Transplant, 15 (11), 1075-83
   PubMed 8956116
3. Gullestad L, Myers J, Noddeland H, Bjørnerheim R, Djøseland O, Hall C, Gieran O, Kjekshus J, Simonsen S (1996)
   Influence of the exercise protocol on hemodynamic, gas exchange, and neurohumoral responses to exercise in heart transplant recipients
   J Heart Lung Transplant, 15 (3), 304-13
   PubMed 8777215
4. Haywood GA, Rickenbacher PR, Trindade PT, Gullestad L, Jiang JP, Schroeder JS, Vagelos R, Oyer P, Fowler MB (1996)
   Analysis of deaths in patients awaiting heart transplantation: impact on patient selection criteria
   Heart, 75 (5), 455-62
   PubMed 8665337
5. Risum O, Abdelnoor M, Svennevig JL, Levorstad K, Gullestad L, Bjørnerheim R, Simonsen S, Nitter-Hauge S (1996)
   Diabetes mellitus and morbidity and mortality risks after coronary artery bypass surgery
   Scand J Thorac Cardiovasc Surg, 30 (2), 71-5
   PubMed 8857678
6. Ross HJ, Gullestad L, Hunt SA, Tovey DA, Puryear JB, McMillan A, Stinson EB, Valantine HA (1996)
   Early Doppler echocardiographic dysfunction is associated with an increased mortality after orthotopic cardiac transplantation
   Circulation, 94 (9 Suppl), II289-93
   PubMed 8901762

Publications 1995

1. Andreassen AK, Gullestad L, Bjørnerheim R, Forfang K, Kjekshus J (1995)
   [Intermittent claudication and beta-blockaders. An unfortunate combination?]
   Tidsskr Nor Laegeforen, 115 (6), 725-8
   PubMed 7900137
2. Forfang K, Gullestad L (1995)
   [Drug therapy of angina pectoris. Are the possibilities exploited well enough?]
   Tidsskr Nor Laegeforen, 115 (18), 2264-7
   PubMed 7652725
3. Gullestad L, Hallén J, Sejersted OM (1995)
   K+ balance of the quadriceps muscle during dynamic exercise with and without beta-adrenoceptor blockade
   J Appl Physiol, 78 (2), 513-23
   PubMed 7759420
4. Gullestad L, Osnes JB (1995)
   [Beta 3-receptors: incidence and properties, possible clinical significance]
   Tidsskr Nor Laegeforen, 115 (1), 45-9
   PubMed 7846660
5. Gullestad L, Simonsen S, Kjekshus J (1995)
   [Reduced physical tolerance in patients with heart failure. Mechanisms and therapeutic effects]
   Tidsskr Nor Laegeforen, 115 (1), 38-42
   PubMed 7846658
6. Simonsen S, Forfang K, Gullestad L, Geiran O (1995)
   [Treatment of terminal heart failure]
   Tidsskr Nor Laegeforen, 115 (4), 467-70
   PubMed 7871502
7. Simonsen S, Gullestad L, Forfang K, Ihlen H, Nordal KP, Geiran O, Høstmark AT (1995)
   [Hypercholesterolemia--a clinical problem in heart transplantation. A therapeutic trial with low-dose lovastatin]
   Tidsskr Nor Laegeforen, 115 (3), 357-9
   PubMed 7855835

Publications 1994

1. Børsheim E, Bahr R, Hansson P, Gullestad L, Hallén J, Sejersted OM (1994)
   Effect of beta-adrenoceptor blockade on post-exercise oxygen consumption
   Metabolism, 43 (5), 565-71
   PubMed 7909912
2. Gullestad L, Jacobsen T, Dolva LO (1994)
   Effect of magnesium treatment on glycemic control and metabolic parameters in NIDDM patients
   Diabetes Care, 17 (5), 460-1
   PubMed 8062622
3. Gullestad L, Midtvedt K, Dolva LO, Norseth J, Kjekshus J (1994)
   The magnesium loading test: reference values in healthy subjects
   Scand J Clin Lab Invest, 54 (1), 23-31
   PubMed 8171268
4. Gullestad L, Nes M, Rønneberg R, Midtvedt K, Falch D, Kjekshus J (1994)
   Magnesium status in healthy free-living elderly Norwegians
   J Am Coll Nutr, 13 (1), 45-50
   PubMed 8157853
5. Hallén J, Gullestad L, Sejersted OM (1994)
   K+ shifts of skeletal muscle during stepwise bicycle exercise with and without beta-adrenoceptor blockade
   J Physiol, 477 ( Pt 1), 149-59
   PubMed 8071881
6. SEJERSTED OM, HALLEN J, GULLESTAD L (1994)
   BETA-ADRENERGIC CONTROL OF POTASSIUM SHIFTS DURING EXERCISE
   EUROPEAN SECTION MEETING - INTERNATIONAL SOCIETY FOR HEART RESEARCH, 151-158

Publications 1993

1. Andreassen AK, Gullestad L (1993)
   [Alpha blockers--first choice or second choice antihypertensive preparations?]
   Tidsskr Nor Laegeforen, 113 (10), 1256-7
   PubMed 8098555
2. Gullestad L, Birkeland K, Mølstad P, Høyer MM, Vanberg P, Kjekshus J (1993)
   The effect of magnesium versus verapamil on supraventricular arrhythmias
   Clin Cardiol, 16 (5), 429-34
   PubMed 8504578
3. Gullestad L, Hallén J, Sejersted OM (1993)
   Variable effects of beta-adrenoceptor blockade on muscle blood flow during exercise
   Acta Physiol Scand, 149 (3), 257-71
   PubMed 7906074

Publications 1992

1. Gullestad L, Dolva LO, Søyland E, Manger AT, Falch D, Kjekshus J (1992)
   Oral magnesium supplementation improves metabolic variables and muscle strength in alcoholics
   Alcohol Clin Exp Res, 16 (5), 986-90
   PubMed 1443440
2. Gullestad L, Dolva LO, Waage A, Falch D, Fagerthun H, Kjekshus J (1992)
   Magnesium deficiency diagnosed by an intravenous loading test
   Scand J Clin Lab Invest, 52 (4), 245-53
   PubMed 1439510
3. Gullestad L, Forfang K, Simonsen S (1992)
   Differential effect of selective beta 1 and nonselective beta-adrenoceptor blockade on epinephrine and atropine response in normal humans
   J Cardiovasc Pharmacol, 20 (6), 976-81
   PubMed 1282602
4. Gullestad L, Kjekshus J (1992)
   [Myocardial disease in diabetes mellitus]
   Tidsskr Nor Laegeforen, 112 (8), 1016-9
   PubMed 1553723
5. Gullestad L, Kjekshus J (1992)
   [Sudden cardiac death. Significance of beta blockaders]
   Tidsskr Nor Laegeforen, 112 (22), 2843-7
   PubMed 1357774

Publications 1991

1. Birkeland KI, Gullestad L, Torsvik H (1991)
   [Cholesterol-lowering effect of oat]
   Tidsskr Nor Laegeforen, 111 (17), 2081-5
   PubMed 1871737
2. Gullestad L, Birkeland K, Nordby G, Larsen S, Kjekshus J (1991)
   Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men
   Br J Clin Pharmacol, 32 (2), 201-7
   PubMed 1681847
3. Gullestad L, Fløgstad T, Nordstrand K, Smith G, Smith H, Frøysaker T, Simonsen S (1991)
   Intrapericardial left atrial aneurysm diagnosed by transoesophageal echocardiography and nuclear magnetic resonance imaging
   Eur Heart J, 12 (2), 277-9
   PubMed 2044565
4. Gullestad L, Oystein Dolva L, Birkeland K, Falch D, Fagertun H, Kjekshus J (1991)
   Oral versus intravenous magnesium supplementation in patients with magnesium deficiency
   Magnes Trace Elem, 10 (1), 11-6
   PubMed 1814318

Publications 1989

1. Gullestad L, Dolva LO, Kjeldsen SE, Eide I, Kjekshus J (1989)
   Effect of beta-adrenergic blockade on hormonal responses during continuous and intermittent exercise
   Cardiovasc Drugs Ther, 3 (1), 63-71
   PubMed 2577280
2. Gullestad L, Dolva LO, Nordby G, Skaaraas K, Larsen S, Kjekshus J (1989)
   The importance of potassium and lactate for maximal exercise performance during beta blockade
   Scand J Clin Lab Invest, 49 (6), 521-8
   PubMed 2574496
3. Gullestad L, Dolva LO, Søyland E, Kjekshus J (1989)
   [Beta blockaders and physical performance. Limiting factors]
   Tidsskr Nor Laegeforen, 109 (25), 2544-7
   PubMed 2573167
4. Gullestad L, Dolva LO, Aase O, Kjekshus J (1989)
   Interaction of naloxone and timolol on maximal exercise capacity and the subjective perception of fatigue
   Int J Sports Med, 10 (4), 259-63
   PubMed 2606592

Publications 1988

1. Gullestad L, Dolva LO, Søyland E, Kjekshus J (1988)
   Difference between beta-1-selective and non-selective beta-blockade during continuous and intermittent exercise
   Clin Physiol, 8 (5), 487-99
   PubMed 3191663

Publications 1987

1. Gullestad L, Dolva LO, Kjeldsen SE, Eide I, Kjekshus J (1987)
   The effects of naloxone and timolol on plasma catecholamine levels during short-term dynamic exercise
   Scand J Clin Lab Invest, 47 (8), 847-51
   PubMed 2893446
2. Gullestad L, Søyland E, Dolva LO, Kjekshus J (1987)
   [Angiotensin-converting enzyme inhibitors in heart failure]
   Tidsskr Nor Laegeforen, 107 (25), 2112-6
   PubMed 2823410
3. Gullestad L, Søyland E, Kjekshus J, Aase O, Bjørnstad P (1987)
   [Magnesium deficiency. Diagnosis and occurrence of different disease conditions]
   Tidsskr Nor Laegeforen, 107 (22), 1751-4
   PubMed 3660356

Publications 1986

1. Gullestad L, Søyland E, Kjekshus J (1986)
   [Magnesium and cardiovascular diseases]
   Tidsskr Nor Laegeforen, 106 (7), 554-7
   PubMed 3961781

Publications 1979

1. Gullestad L, Krüger MB, Krüger O, Bakketeig LS (1979)
   [Smoking habits among pregnant women in Trøndelag]
   Tidsskr Nor Laegeforen, 99 (12), 575-9
   PubMed 442031